Publications

Examining the risk of hospitalization within 14 days of COVID-19 diagnosis among people living with HIV (PLWH) and HIV-negative individuals who had laboratory-confirmed SARS-CoV-2 infection.

Considering the prevalence of HPgV in a cohort of HCV/HIV co-infected patients undergoing treatment for HCV with direct acting antivirals (DAA) and investigate the effect of DAA therapy on HPgV infection.

Considering temporal changes in plasma proteins following SARS-CoV-2 infection and pre-infection proteomic markers associated with future COVID-19

Considering the effects of host factors and COVID-19 on the humoral repertoire in people living with HIV.

Considering the impact of COVID-19 on Two-Spirit, lesbian, gay, bisexual, transgender, and queer (2SLGBTQ+) populations in Canada

Considering the relationship between inflammasome activation and coronary plaque.

Discussing cognitive remediation group therapy as an in-person intervention for people aging with HIV

Considering potential links between childhood trauma, trauma-related stressors, and methamphetamine use among GBM.

Assessing the effects of oral cannabinoids on HIV.

Considering the different objectives and needs of cannabis products for medical and recreational purposes.